For patients facing a terminal illness, the primary medical goal often shifts from curing the disease to palliative care—ensuring the final chapter of life is as comfortable and dignified as possible. When it comes to cannabis for terminally ill patients in Virginia. it provides relief that pharmaceutical opioids and sedatives simply cannot match. However, patients currently face a cruel choice when entering a hospital or hospice facility: give up their plant-based medicine or risk being denied care due to federal restrictions.
A new piece of legislation, House Bill 75 (HB75), aims to dismantle this barrier. Introduced by Delegate Karen Keys-Gamarra for the 2026 legislative session, this bill proposes a mandate that would require Virginia medical care facilities to permit terminally ill patients to use medical cannabis. While this represents a monumental step toward compassionate care, the bill comes with significant restrictions that may limit its effectiveness for the very people it aims to help.
What HB75 Promises for Patients
The core of HB75 is rooted in compassion. It seeks to amend the Code of Virginia to ensure that a “medical care facility shall permit a patient to use medical cannabis.” Under the bill, a “patient” is defined as someone with a terminal illness and a life prognosis of one year or less.
Currently, many hospitals and nursing homes prohibit cannabis use entirely because it currently still remains a Schedule I drug at the federal level. This forces patients to choose between staying in a facility to receive necessary nursing care or staying home to access the medicine that manages their pain and anxiety.
If passed, HB75 would require facilities to:
- Adopt policies that facilitate the use of medical cannabis.
- Include the use of cannabis in the patient’s official medical records.
- Allow patients to possess and consume their medicine on the premises, provided they have a written certification from a practitioner.
This legislation signals that the state recognizes cannabis as a legitimate, essential component of end-of-life care, rather than an illicit substance to be banned from medical grounds.
The “No Smoke” Rule and Other Restrictions
While the bill opens the door for access, it strictly limits how patients can walk through it. One of the most glaring restrictions in HB75 is the explicit prohibition of smoking or vaping. The text states that facilities must “prohibit smoking or vaping as methods to use medical cannabis.”
For a cannabis-friendly advocate, this restriction raises questions about bodily autonomy. While hospitals have valid reasons for banning combustion—such as the presence of oxygen tanks and the need to maintain a sterile environment—vaping is often a preferred method for patients needing immediate relief.
Edibles and tinctures, while effective, can take 45 minutes to an hour to kick in. When a terminally ill patient experiences a sudden spike in breakthrough pain or nausea, they may not have an hour to wait. Inhalation offers near-instant onset. By banning vaping entirely, the bill removes one of the most effective tools for rapid symptom management. If a patient is in their final days, restricting their preferred method of consumption feels like an unnecessary bureaucratic hurdle rather than a medical necessity.
Additionally, the bill mandates that facilities “reasonably restrict” how cannabis is stored, requiring locked containers. While safety is important to protect other patients and staff, these strict storage protocols could make it difficult for patients with limited mobility to access their medicine independently.
The Federal Loophole: A Fragile Protection
Perhaps the most significant weakness of HB75 lies in Subsection E, which effectively gives the federal government a “kill switch” for the program.
Most hospitals and nursing homes rely heavily on funding from the Centers for Medicare and Medicaid Services (CMS). Because cannabis is still illegal federally, facilities often fear losing their funding. HB75 addresses this fear by offering facilities an out.
The bill states that if a federal agency, the U.S. Department of Justice (DOJ), or CMS initiates enforcement action or issues a rule prohibiting medical marijuana in these facilities, the facility “may suspend compliance.”
This means that if the federal government decides to pressure Virginia hospitals, the state mandate dissolves. A facility could simply point to a letter or rule from CMS and revoke a patient’s right to use their medicine. This clause may be essential to pass the bill and prevent hospitals from going bankrupt, but it puts patients in a vulnerable position. The state does not guarantee their access to medicine; instead, it depends on the federal government choosing to overlook the issue.
Why We Need Stronger Protections
House Bill 75 is a commendable effort to bring humanity into the rigid world of medical regulation. No person in their final days should have to hide their medicine or suffer solely because of outdated drug laws. Delegate Keys-Gamarra’s proposal validates the experience of thousands of Virginians who rely on cannabis for dignity and comfort.
However, the bill highlights the continued struggle between state compassion and federal prohibition. The restrictions on smoking and vaping limit patient choice, and a federal loophole means the DOJ could revoke access at any time.
As Virginia moves toward the 2026 session, advocates will need to voice support for the intent of this bill while pushing for a future where terminally ill patients have true autonomy over their treatment options—without caveats, locked boxes, or fear of federal intervention.
